心血管植入式电子设备初次感染后重新植入的再感染率

O. Anyagwa, Fatema Rampurawala, Lama Alchaar, Taymaa Gharib, Miyukta Ravuri, Kulsum Fatima, Namrata Mishra, Rutvi Bhatt, Maha Essakkiraj, Rajeeka Tak, Maha Kassem
{"title":"心血管植入式电子设备初次感染后重新植入的再感染率","authors":"O. Anyagwa, Fatema Rampurawala, Lama Alchaar, Taymaa Gharib, Miyukta Ravuri, Kulsum Fatima, Namrata Mishra, Rutvi Bhatt, Maha Essakkiraj, Rajeeka Tak, Maha Kassem","doi":"10.33590/emjintcardiol/11000027","DOIUrl":null,"url":null,"abstract":"Cardiovascular implantable electronic device (CIED) infections have become an increasing problem around the world, affecting one in 20 patients within 3 years of device implementation. Prevention of reinfection following CIED reimplantation is a prominent challenge. One of the most difficult aspects of managing CIED infections is the complexities of their diagnosis: with the complexities of many infections, timely and correct diagnosis becomes complicated, frequently causing delays in commencing proper therapy, and worsening disease severity. As patients receiving CIED therapy are now older, and possess significant comorbidities, they are at a higher risk of infection. The American Heart Association (AHA) has issued a statement to educate clinicians about CIED infections, and the required care for those with suspected or diagnosed infections. To prevent an infection from spreading, it is important to isolate the causative pathogen and perform testing for susceptibility, which is required for crucial choices, including routes and duration of antimicrobial therapy. This review aims to serve as a valuable resource for healthcare professionals, by synthesising current knowledge and best practices; and providing insights into preventive measures, diagnostic challenges, therapeutic strategies, and evidence-based approaches to diagnose and improve the management of CIED infections in an ageing and medically complex patient population.","PeriodicalId":505264,"journal":{"name":"EMJ Interventional Cardiology","volume":"54 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reinfection Rates Following Cardiovascular Implantable Electronic Device Reimplementation Post-device Primary Infection\",\"authors\":\"O. Anyagwa, Fatema Rampurawala, Lama Alchaar, Taymaa Gharib, Miyukta Ravuri, Kulsum Fatima, Namrata Mishra, Rutvi Bhatt, Maha Essakkiraj, Rajeeka Tak, Maha Kassem\",\"doi\":\"10.33590/emjintcardiol/11000027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cardiovascular implantable electronic device (CIED) infections have become an increasing problem around the world, affecting one in 20 patients within 3 years of device implementation. Prevention of reinfection following CIED reimplantation is a prominent challenge. One of the most difficult aspects of managing CIED infections is the complexities of their diagnosis: with the complexities of many infections, timely and correct diagnosis becomes complicated, frequently causing delays in commencing proper therapy, and worsening disease severity. As patients receiving CIED therapy are now older, and possess significant comorbidities, they are at a higher risk of infection. The American Heart Association (AHA) has issued a statement to educate clinicians about CIED infections, and the required care for those with suspected or diagnosed infections. To prevent an infection from spreading, it is important to isolate the causative pathogen and perform testing for susceptibility, which is required for crucial choices, including routes and duration of antimicrobial therapy. This review aims to serve as a valuable resource for healthcare professionals, by synthesising current knowledge and best practices; and providing insights into preventive measures, diagnostic challenges, therapeutic strategies, and evidence-based approaches to diagnose and improve the management of CIED infections in an ageing and medically complex patient population.\",\"PeriodicalId\":505264,\"journal\":{\"name\":\"EMJ Interventional Cardiology\",\"volume\":\"54 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMJ Interventional Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33590/emjintcardiol/11000027\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ Interventional Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjintcardiol/11000027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

心血管植入式电子设备(CIED)感染已成为全球范围内日益严重的问题,每 20 名患者中就有一人在设备使用 3 年内受到感染。预防 CIED 再植入后的再感染是一个突出的挑战。处理 CIED 感染最困难的方面之一是其诊断的复杂性:由于许多感染的复杂性,及时和正确的诊断变得复杂,经常导致开始适当治疗的延误,并使疾病的严重程度恶化。由于目前接受 CIED 治疗的患者年龄较大,合并症较多,因此感染风险较高。美国心脏协会(AHA)已发表声明,向临床医生宣传 CIED 感染以及对疑似或确诊感染者的必要护理。为防止感染扩散,必须隔离致病病原体并进行药敏试验,这对选择抗菌药物治疗的途径和疗程等至关重要。本综述旨在综合当前的知识和最佳实践,为医护专业人员提供有价值的资源;深入探讨预防措施、诊断难题、治疗策略和循证方法,以诊断和改善老龄化和医疗复杂的患者群体中的 CIED 感染管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Reinfection Rates Following Cardiovascular Implantable Electronic Device Reimplementation Post-device Primary Infection
Cardiovascular implantable electronic device (CIED) infections have become an increasing problem around the world, affecting one in 20 patients within 3 years of device implementation. Prevention of reinfection following CIED reimplantation is a prominent challenge. One of the most difficult aspects of managing CIED infections is the complexities of their diagnosis: with the complexities of many infections, timely and correct diagnosis becomes complicated, frequently causing delays in commencing proper therapy, and worsening disease severity. As patients receiving CIED therapy are now older, and possess significant comorbidities, they are at a higher risk of infection. The American Heart Association (AHA) has issued a statement to educate clinicians about CIED infections, and the required care for those with suspected or diagnosed infections. To prevent an infection from spreading, it is important to isolate the causative pathogen and perform testing for susceptibility, which is required for crucial choices, including routes and duration of antimicrobial therapy. This review aims to serve as a valuable resource for healthcare professionals, by synthesising current knowledge and best practices; and providing insights into preventive measures, diagnostic challenges, therapeutic strategies, and evidence-based approaches to diagnose and improve the management of CIED infections in an ageing and medically complex patient population.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信